Palle B Jeppesen Selected Research

Short Bowel Syndrome

5/2022	Effects of glepaglutide, a long-acting glucagon-like peptide-2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trial.
1/2022	Apraglutide, a novel once-weekly glucagon-like peptide-2 analog, improves intestinal fluid and energy absorption in patients with short bowel syndrome: An open-label phase 1 and 2 metabolic balance trial.
1/2022	Apraglutide, a novel glucagon-like peptide-2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: Findings from a placebo-controlled, randomized phase 2 trial.
1/2020	Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials.
1/2020	Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
1/2020	Colon polyps in patients with short bowel syndrome before and after teduglutide: Post hoc analysis of the STEPS study series.
1/2019	The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: A systematic review.
1/2019	Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial.
1/2019	Novel Long-Acting GLP-2 Analogue, FE 203799 (Apraglutide), Enhances Adaptation and Linear Intestinal Growth in a Neonatal Piglet Model of Short Bowel Syndrome with Total Resection of the Ileum.
1/2018	Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Palle B Jeppesen Research Topics

Disease

24	Short Bowel Syndrome 05/2022 - 01/2006
16	Intestinal Failure 01/2022 - 12/2012
4	Sepsis (Septicemia) 02/2018 - 02/2016
4	Bone Resorption 02/2013 - 07/2007
3	Body Weight (Weight, Body) 01/2018 - 06/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 01/2018
2	Diarrhea 01/2018 - 05/2014
2	Abdominal Pain (Pain, Abdominal) 02/2016 - 05/2014
1	Colic (Abdominal Cramps) 10/2021
1	Polyps 01/2020
1	Insulin Resistance 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Infections 01/2018
1	Obesity 01/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Rare Diseases (Rare Disease) 01/2018
1	Intestinal Volvulus (Volvulus) 01/2018
1	Dehydration (Water Stress) 05/2014
1	Nausea 05/2014
1	Malnutrition (Nutritional Deficiencies) 05/2014
1	Osteoporosis 02/2013
1	Metabolic Bone Diseases (Osteopenia) 01/2008
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 06/2007

Drug/Important Bio-Agent (IBA)

14	teduglutideIBA 01/2020 - 12/2012
10	Glucagon (Glukagon)FDA Link 05/2022 - 07/2007
5	Glucagon-Like Peptide 2IBA 06/2014 - 07/2007
4	Hormones (Hormone)IBA 01/2019 - 07/2007
3	apraglutideIBA 01/2022 - 01/2019
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 01/2018
2	Glucagon-Like Peptides (Enteroglucagon)IBA 02/2015 - 01/2006
2	Collagen Type I (Type I Collagen)IBA 02/2013 - 07/2007
1	CoagulaseIBA 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2018
1	Citric Acid (Citrate)FDA LinkGeneric 09/2017
1	taurolidineIBA 09/2017
1	Heparin (Liquaemin)FDA LinkGeneric 09/2017
1	Serum AlbuminIBA 02/2016
1	Human Growth Hormone (Saizen)FDA LinkGeneric 05/2014
1	ElectrolytesIBA 05/2014
1	MicronutrientsIBA 05/2014
1	Biomarkers (Surrogate Marker)IBA 08/2008
1	Parathyroid Hormone (Parathormone)IBA 01/2008
1	collagen type I trimeric cross-linked peptideIBA 07/2007
1	Trefoil FactorsIBA 06/2007
1	Therapeutic UsesIBA 06/2007
1	Peptides (Polypeptides)IBA 06/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2006
1	Growth Hormone (Somatotropin)IBA 01/2006

Therapy/Procedure

4	Jejunostomy 10/2021 - 01/2008
4	Catheters 02/2018 - 02/2016
3	Parenteral Nutrition 01/2020 - 05/2014
3	Ileostomy 01/2018 - 01/2008
2	Subcutaneous Injections 05/2022 - 02/2013
2	Home Parenteral Nutrition 02/2018 - 07/2013
1	Aftercare (After-Treatment) 01/2020
1	Central Venous Catheters 01/2018
1	Injections 01/2008
1	Gastrectomy 07/2007
1	Fluid Therapy (Oral Rehydration Therapy) 01/2006